BH-3 stapled alpha-helical peptides (Aileron)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameBH-3 stapled alpha-helical peptides (Aileron)
Drug Alias NameBIDspBIMspMCL-1 BH3ATSP-1407ATSP-1505 +[11] 
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionApoptosis regulator BAX modulatorsInduced myeloid leukemia cell differentiation protein Mcl-1 inhibitorsApoptosis stimulants
TargetsApoptosis regulator BAXInduced myeloid leukemia cell differentiation protein Mcl-1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRein Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRein Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A